tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (WXIBF)
OTHER OTC:WXIBF

Wuxi Biologics (Cayman) (WXIBF) Revenue

Compare
161 Followers

Wuxi Biologics (Cayman) Revenue

Wuxi Biologics (Cayman) had a revenue of 9.95B in the quarter ending Jun 30, 2025, with -1.46%. This bring the company's revenue in the last twelve months to 20.05B, Decreased 7.38%. In the fiscal year ending Dec 31, 2024, Wuxi Biologics (Cayman) had annual revenue of 18.68B with 9.63% growth.
Revenue (ttm)
20.05B
Revenue Growth
P/S Ratio
0.96
Revenue/Employee
$1,485,119
Employees
12,575
Market Cap
$18.02B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.68B1.64B+9.63%
Dec 31, 2023
17.03B1.77B+11.56%
Dec 31, 2022
15.27B4.98B+48.38%
Dec 31, 2021
10.29B4.68B+83.35%
Dec 31, 2020
5.61B1.63B+40.88%
Dec 31, 2019
3.98B1.45B+57.18%
Dec 31, 2018
2.53B915.62M+56.56%
Dec 31, 2017
1.62B